Balanced news tone
News Sentiment
TEVA sentiment intelligence
Teva Pharma Industries Ltd ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
-4.9% over one week, -4.9% over four weeks, trend active, and materially above fair value.
Colin Cieszynski's Past Picks: First Quantum Minerals, Teva Pharmaceuticals & BMO Global Gold Index
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Colin Cieszynski's Past Picks: First Quantum Minerals, Teva Pharmaceuticals & BMO Global Gold Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 17:35
- Source
- BNN Bloomberg
Teva Pharmaceutical Industries (TEVA) Advances TEV 408, Is The Stock Still Cheap?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:16
- Source
- simplywall.st
Teva Pharmaceutical Industries (TEVA) Could Be 21% Below Fair Value On Vitiligo Trial Progress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 04:31
- Source
- Market source
US appeals court revives Teva lawsuit over Lilly osteoporosis drug
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 13 Jul 2026 21:37
- Source
- Reuters
Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 07:13
- Source
- Stocktwits
Teva Pharmaceutical Industries’ Anti-IL-15 Antibody Shows Promise in Vitiligo Study
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 22:02
- Source
- MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) Cut to "Hold" at Wall Street Zen
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 12 Jul 2026 17:43
- Source
- MarketBeat
Is Teva Pharmaceutical Industries Limited (TEVA) Stock Undervalued After Recent Pullback and Vitiligo Program Update?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Teva Pharmaceutical Industries (TEVA) Stock After 94% One-Year Surge Is The Price Justified
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- simplywall.st
Teva Pharmaceutical Industries Just Pulled Off One of Pharma's Most Impressive Comebacks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- Market source
Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Market source